Psyence Biomedical Ltd. (PBM) Current Assets (2023 - 2026)
Psyence Biomedical (PBM) posted quarterly Current Assets of $9.1 million for Q1 2026, up 38.87% year-over-year from $6.6 million in Q1 2025, and up 19.41% quarter-over-quarter from $7.6 million in Q3 2025.
Psyence Biomedical Ltd. (PBM) Current Assets (2023 - 2026) Analysis & Trends
Psyence Biomedical's Current Assets history runs 4 years deep, the most recent figure standing at $9.1 million for Q1 2026.
- In Q1 2026, Current Assets rose 38.87% year-over-year to $9.1 million; the TTM figure through Mar 2026 stood at $9.1 million (up 38.87% YoY), while the FY2026 annual figure was $9.1 million, up 38.87% from the prior year.
- Current Assets for Q1 2026 stood at $9.1 million, up from $7.6 million in the prior quarter.
- The five-year high for Current Assets was $162.5 billion in Q3 2023, with the low at $1.1 million in Q1 2024.
- The 4-year median for Current Assets is $6.6 million (2025), against an average of $23.2 billion.
- The sharpest annual moves came in 2024 and 2025: Current Assets plunged 100.0% in 2024, then soared 482.27% in 2025.
- Psyence Biomedical's Current Assets stood at $162.5 billion in 2023, then slumped by 100.0% to $2.2 million in 2024, then jumped by 240.09% to $7.6 million in 2025, then rose by 19.41% to $9.1 million in 2026.
- Business Quant data shows PBM's Current Assets at $9.1 million in Q1 2026, $7.6 million in Q3 2025, and $6.6 million in Q1 2025.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.11 Mn |
| Sep 30, 2025 | 7.63 Mn |
| Mar 31, 2025 | 6.56 Mn |
| Sep 30, 2024 | 2.24 Mn |
| Mar 31, 2024 | 1.13 Mn |
| Sep 30, 2023 | 162.52 Bn |
| Mar 31, 2023 | 1.83 Mn |